Gradalis, Inc.

This study is testing whether a personalized vaccine called Vigil can help women with advanced ovarian cancer stay cancer-free longer after their initial surgery and chemotherapy. The vaccine is made from each patient's own tumor cells and is given as a series of injections. Rese…